U.S. markets close in 2 hours 45 minutes
  • S&P 500

    3,805.40
    -16.15 (-0.42%)
     
  • Dow 30

    30,941.35
    -5.64 (-0.02%)
     
  • Nasdaq

    11,122.62
    -58.92 (-0.53%)
     
  • Russell 2000

    1,710.31
    -28.53 (-1.64%)
     
  • Crude Oil

    111.60
    -0.16 (-0.14%)
     
  • Gold

    1,818.00
    -3.20 (-0.18%)
     
  • Silver

    20.75
    -0.12 (-0.58%)
     
  • EUR/USD

    1.0454
    -0.0072 (-0.68%)
     
  • 10-Yr Bond

    3.1100
    -0.0960 (-2.99%)
     
  • GBP/USD

    1.2133
    -0.0052 (-0.42%)
     
  • USD/JPY

    136.5220
    +0.3940 (+0.29%)
     
  • BTC-USD

    20,009.14
    -636.12 (-3.08%)
     
  • CMC Crypto 200

    430.33
    -9.34 (-2.12%)
     
  • FTSE 100

    7,312.32
    -11.09 (-0.15%)
     
  • Nikkei 225

    26,804.60
    -244.87 (-0.91%)
     

Ionis to hold virtual investor day event

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Webcast scheduled for Thursday, Dec. 9 at 11:00 a.m. Eastern Time

CARLSBAD, Calif., Dec. 2, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a virtual investor day on Thursday, December 9th at 11:00 a.m. Eastern Time. The company will provide an overview of its strategy, plans, and progress to bring its most advanced programs to market and achieve commercial success as well as highlight key technology advances. The webcast is expected to last approximately 2.5 hours.

(PRNewsfoto/Ionis Pharmaceuticals, Inc.)
(PRNewsfoto/Ionis Pharmaceuticals, Inc.)

Interested parties may access the webcast at https://www.ionispharma.com/investor-day. A replay will be available for a limited time at the same address.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.

To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-virtual-investor-day-event-301436652.html

SOURCE Ionis Pharmaceuticals, Inc.